Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in Diabetic Kidney Disease
NCT01847313Phase 3Completed
- Start
- Apr 2013
- Primary completion
- Nov 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in diabetic kidney disease (DKD). Started Apr 2013; status: completed.
02
Drugs
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT01847313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01847313.